ArsenalBio is fighting cancer by developing next generation T cell therapies.
Leadership
Ken Drazan
Fund
SVF2
Status
Private
Sector
Health Tech
Region
EMEA
Insights
Q&A
Ken Drazan: Building an LLM that speaks the language of the immune system
How ArsenalBio is targeting cancers and accelerating the speed of biomedical research
Roundup
Data and ML are creating a golden age of drug discovery
The biotech sector is poised to reap the benefits of the AI revolution, with lifesaving effects